The pharmaceutical sector, as one of the most profitable sectors in the context of an aging population, has attracted much attention in the market. At the same time, the pharmaceutical sector is also a sector that is greatly affected by policies, which makes the company's performance not fully reflect its research and development strength. The pharmaceutical index has been operating in a large box for the past two years. Perhaps in the future, with the release of some heavyweight new drugs by listed companies, the pharmaceutical index may break through the box and open a new upward channel.